Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA LTD

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 36
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

IPCA LABS

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 38
  • 0 comments

FDA approve LAMOTRIGINE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 36
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

PAI HOLDINGS PHARM

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 34
  • 0 comments

FDA approve HYDROXYZINE HYDROCHLORIDE

Comment Full text

UNIQUE

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 34
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

SANDOZ

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 31
  • 0 comments

FDA approve AMPICILLIN SODIUM; SULBACTAM SODIUM

Comment Full text

INFORLIFE

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 35
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

ZHEJIANG JUTAI PHARM

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 36
  • 0 comments

FDA approve AMANTADINE HYDROCHLORIDE

Comment Full text

UNIQUE

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 40
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 38
  • 0 comments

FDA approve PENCICLOVIR

Comment Full text
  • Previous
  • 294
  • 295
  • 296
  • 297
  • 298
  • Next

Search

News categories

  • Technical Exchange News(10602)
  • Event(2021)
  • SEC News(184969)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122496)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin